Faculty Dilawar Khan 1

Dilawar Khan

Assistant Professor
  • Atta-Ur-Rahman School of Applied Biosciences
  • 5190856139
Summary

Academic Background
PhD (Cancer Biology/Cancer Stem Cells & Signaling/Biotech/Molecular Bio) Johann Wolfgang Goethe Universität Frankfurt am Main April 01, 2012 - May 23, 2016
Honours and Awards
Scholarship Merit Scholarship throughout under graduate studies
PhD Scholarship Germaany PhD Scholarship for Germany under HEC 90% Overseas PhD scholarship, Phase II BATCH 3 Rs: 5.5 million October 01, 2011
2nd Runner Up prize 2nd Runner Up prize, FICS 2018, NUST
Publications
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia October 01, 2022 Claudia Chirichi, Dilawar Khan, Maria Wieske, Nathalie Guillen, Michal Rokicki, Carol Guy, Marieangela Wilson, Kate J. Heesom, Oliver Gerhard Ottmann, Martin Ruthardt, Annals of Hematology - Volume 101, Issue 10, Pages 2179-2193
Biomarkers in Tumor Recurrence and Metastasis May 28, 2022 Dilawar Khan, Mudassir Khan, Book on Cancer Biomarkers in Diagnosis and Therapeutics - 1st Edition, Chapter 8, Pages 201-227
Prevalence and assessment of associated risk factors of hepatitis B and C infections in low-socioeconomic communities May 01, 2022 Aisha Noreen, Naik Alam, Zainab Syed, Aroosa Aftab, Farah Shamim, Syed Najeebullah, Dilawar Khan, Salik Javed Kakar, Tahir Ahmed, Fazal Adnan, Future Virology - Volume 17, Issue 5, Pages 291-303
Silencing of Curlin Protein via M13 Phagemid‐Mediated Synthetic sRNA Expression Reduces Virulence in the Avian Pathogenic E. coli (APEC) February 14, 2022 Sayed Abdullah, Quratul Ain, Amna Jalil, Dilawar Khan, Arsalan Khan, Muhammad Qasim, Malik Badshah, Fazal Adnan, Current Microbiology - Volume 79, Article Number: 105
AXL Receptor Tyrosine Kinase: A Possible Therapeutic Target in Acute Promyelocytic Leukemia June 17, 2021 Mariam Fatima, Salik Javed Kakar, Fazal Adnan, Khalid Khan, Afsar Ali Mian, Dilawar Khan, BMC Cancer - Volume 21, Article Number 713
A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19 May 26, 2021 Mudassir Khan, Muhammad Abubakar Sadique, Huzaifa Tahir, Muhammad Dawood Amjad, Abdullah Ahmad, Usama Masood, Dilawar Khan, Infectious Disorders Drug Targets - Pages 1-8
In Silico Identification of Novel Acute Myeloid Leukemia Associated Missense SNPs in Human CEBPA Gene December 31, 2020 Mudassir Khan, Mehran Akhtar, Maharij Haroon Jadoon, Dilawar Khan, Abasyn Journal of Life Sciences - Volume 3, Issue 2, Pages 10-24
Insights into Acute Myeloid Leukemia: Critical Analysis on its Wide Aspects December 31, 2020 Mudassir Khan, Misbahud Din, Zerbab Naeem, Zahra Sajid, Dilawar Khan, Muhammad Dawood Amjad, Aurang Zeb, Faheem Anwar, Mehran Akhtar, Sana Noreen, Abasyn Journal of Life Sciences - Volume 3 Issue 2, Pages 1-9
5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia September 15, 2014 Jessica Roos, Claudia Oancea, Maria Heinssmann, Dilawar Khan, Hannelore Held, Astrid S. Kahnt, Ricardo Capelo, Estel la Buscato, Ewgenij Proschak, Elena Puccetti, Dieter Steinhilbe, Ingrid Fleming, Thorsten J. Maier, Martin Ruthardt, Cancer Research - Volume 74, Issue 18, Pages 5244-5255
Conferences
Induction of Fetal Hemoglobin by Targeted Deletion of Zinc Finger Domain Within BCL11A Gene using CRISPR-CAS9 Technology June 08, 2023 - June 11, 2023 Irfan Hussain, Kainaat Mumtaz, Fizza Iftikhar, Safana Farooq, Syed Muhammad Areeb Ahmed, Dilawar Khan, Hammad Hass, Oliver Ottmann, Afsar Ali Mian, European Hematology association congress 2023
ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA June 08, 2023 - June 11, 2023 Syeda Maham, Saba Naseem Awan, Fazal Adnan, Salik Javed Kakar, Afsar Ali Mian, Dilawar Khan, European Hematology association congress 2023
Post Doc fellow Agha Khan University May 18, 2017 - September 17, 2017